Publicaciones en las que colabora con AINHOA URRUTIA LOSADA (11)

2024

  1. [Translated article] Pharmaceuticals in the environment: A hospital pharmacy perspective

    Farmacia Hospitalaria, Vol. 48, pp. TS13-TS20

2022

  1. Adequacy of the use of antibiotic prophylaxis in urinary tract infection in primary care of the Alto Deba Integrated Health Organization

    Atencion Primaria Practica, Vol. 4, Núm. 1

  2. Multidisciplinary Collaboration for the Optimization of Antibiotic Prescription: Analysis of Clinical Cases of Pneumonia between Emergency, Internal Medicine, and Pharmacy Services

    Antibiotics, Vol. 11, Núm. 10

2021

  1. Fosfomycin: Salt is what really matters

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 4, pp. 206-207

  2. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  3. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

2012

  1. Estudio comparativo de eficacia y seguridad de dos protocolos antieméticos en quimioterapia ginecológica

    Farmacia Hospitalaria, Vol. 36, Núm. 4, pp. 220-228

  2. Explicit appropriateness prescription criteria in advanced dementia. Are we there yet?

    European Geriatric Medicine

2010

  1. Evolución de la adherencia al tratamiento antirretoviral del 2000 al 2008

    Farmacia Hospitalaria, Vol. 34, Núm. 6, pp. 279-283

2008

  1. Tratamiento de la degeneración macular asociada a la edad con bevacizumab intravítreo: Papel del servicio de farmacia

    Atencion Farmaceutica, Vol. 10, Núm. 2, pp. 79-82